Intellia Therapeutics, Inc. ($NTLA)
Filing Information
| Accession Number | 0001193125-26-006264 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
2,989
Total Value
$27,528.69
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VP, Chief Accounting Officer | Common Stock | โ | Jan 5, 2026 | Sale | 2,989 | $9.21 | $27,528.69 | 52,277 | Direct | โ | View Details |